88 related articles for article (PubMed ID: 10757085)
1. Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domains.
Kitson RP; Lu M; Siman R; Goldfarb RH
In Vivo; 2000; 14(1):265-8. PubMed ID: 10757085
[TBL] [Abstract][Full Text] [Related]
2. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex.
Wasserman K; Kitson RP; Rivett AJ; Sweeney ST; Gabauer MK; Herberman RB; Watkins SC; Goldfarb RH
J Cell Biochem; 1994 May; 55(1):133-45. PubMed ID: 8083294
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical localization of multicatalytic protease complex (proteasome) during generation of murine IL-2-activated natural killer (A-NK) cells.
Nannmark U; Kitson RP; Johansson BR; Rivett AJ; Goldfarb RH
Eur J Cell Biol; 1996 Dec; 71(4):402-8. PubMed ID: 8980912
[TBL] [Abstract][Full Text] [Related]
4. Activation of multiple caspases and modification of cell surface fas (CD95) in proteasome inhibitor-induced apoptosis of rat natural killer cells.
Lu M; Kitson RP; Xue Y; Goldfarb RH
J Cell Biochem; 2003 Feb; 88(3):482-92. PubMed ID: 12532325
[TBL] [Abstract][Full Text] [Related]
5. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts.
An B; Goldfarb RH; Siman R; Dou QP
Cell Death Differ; 1998 Dec; 5(12):1062-75. PubMed ID: 9894613
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class I.
Wu X; Shao Y; Tao Y; Ai G; Wei R; Meng X; Hou J; Han Y; Zhan F; Zheng J; Shi J
Biochem Biophys Res Commun; 2011 Nov; 415(1):187-92. PubMed ID: 22033416
[TBL] [Abstract][Full Text] [Related]
8. Non-granular proteolytic enzymes of rat interleukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2, and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to interleukin-2.
Kitson RP; Miller CA; Goldfarb RH
Nat Immun; 1995 Sep; 14(5-6):286-94. PubMed ID: 8933822
[TBL] [Abstract][Full Text] [Related]
9. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
Nam S; Smith DM; Dou QP
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
[TBL] [Abstract][Full Text] [Related]
10. Cellular redox status influences both cytotoxic and NF-kappa B activation in natural killer cells.
Valle Blázquez M; Luque I; Collantes E; Aranda E; Solana R; Peña J; Muñoz E
Immunology; 1997 Mar; 90(3):455-60. PubMed ID: 9155655
[TBL] [Abstract][Full Text] [Related]
11. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
[TBL] [Abstract][Full Text] [Related]
12. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
13. The effects of lovastatin on proteasome activities in highly purified rabbit 20 S proteasome preparations and mouse MC3T3-E1 osteoblastic cells.
Murray SS; Tu KN; Young KL; Murray EJ
Metabolism; 2002 Sep; 51(9):1153-60. PubMed ID: 12200760
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
Kazi A; Daniel KG; Smith DM; Kumar NB; Dou QP
Biochem Pharmacol; 2003 Sep; 66(6):965-76. PubMed ID: 12963483
[TBL] [Abstract][Full Text] [Related]
15. Identification and enrichment of proteolytic enzymes of IL-2 activated rat natural killer (A-NK) cells: potential physiological roles in NK cell function.
Kitson RP; Wasserman K; Goldfarb RH
Immunol Ser; 1994; 61():83-92. PubMed ID: 8011759
[No Abstract] [Full Text] [Related]
16. Lithium chloride inactivates the 20S proteasome from WEHI-3B D+ leukemia cells.
Holtz KM; Rice AM; Sartorelli AC
Biochem Biophys Res Commun; 2003 Apr; 303(4):1058-64. PubMed ID: 12684043
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides.
Lum RT; Nelson MG; Joly A; Horsma AG; Lee G; Meyer SM; Wick MM; Schow SR
Bioorg Med Chem Lett; 1998 Feb; 8(3):209-14. PubMed ID: 9871656
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals).
Lynas JF; Harriott P; Healy A; McKervey MA; Walker B
Bioorg Med Chem Lett; 1998 Feb; 8(4):373-8. PubMed ID: 9871688
[TBL] [Abstract][Full Text] [Related]
19. Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification.
Wilk S; Pereira M; Yu B
Biomed Biochim Acta; 1991; 50(4-6):471-8. PubMed ID: 1801711
[No Abstract] [Full Text] [Related]
20. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.
Smith DM; Daniel KG; Wang Z; Guida WC; Chan TH; Dou QP
Proteins; 2004 Jan; 54(1):58-70. PubMed ID: 14705024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
